St. Gallen Report 2013 1.00
Continue to app
Paid Version
Publisher Description
This app presents a 25-page report of 13th St. Gallen International Breast Cancer Consensus Conference highlighting some of the controversial areas discussed during this meeting and is intended for healthcare professionals. The recognition that early breast cancer is a spectrum of diseases each requiring a specific systemic therapy guided the consensus conference. The meeting comprised of 3,600 participants from nearly 90 countries worldwide, which included clinical oncologists, pathologists, surgeons, gynaecologists, epidemiologists, breast cancer nurses and basic scientists. The consensus conference was co-chaired by Aron Goldhirsch (Switzerland/Italy) and Eric Winer (USA). The consensus was generated when panel members considered and voted on a number of questions in key areas of controversy. Educational content centred on the primary and multidisciplinary treatment approach of early breast cancer. On the final day, the meeting culminated with the St. Gallen Breast Cancer Treatment Consensus, which was established by the world s most skilled opinion leaders in the field of breast cancer treatment. The principal aim of the 2013 St Gallen consensus conference was to provide rational recommendations for personalising the approach to treatment of early breast cancer in women. The key issues that were highlighted included: 1. Tumour biology to determine responsiveness to various treatments 2. Tumour extent to estimate the level of benefit when justifying treatment for the individual patient 3. Estimates of the risks of therapy and patient preference to define preferred management The areas of controversy discussed during the meeting were: 1. Surgery of the primary 2. Surgery of the axilla 3. Radiation - partial breast, post-mastectomy, nodal areas, advanced technologies 4. Pathology 5. Multigene signatures 6. Stroma - extracellular matrix and prognosis 7. Endocrine therapies ovarian suppression, tamoxifen, aromatase inhibitors 8. Chemotherapies - luminal A, duration, regimen 9. Anti-HER2 therapies - combination, duration 10. Neo-adjuvant systemic therapy 11. Bisphosphonates - anti-tumour effects 12. Follow-up after early breast cancer
Requires iOS 4.3 or later. Compatible with iPhone, iPad, and iPod touch.
About St. Gallen Report 2013
St. Gallen Report 2013 is a paid app for iOS published in the Health & Nutrition list of apps, part of Home & Hobby.
The company that develops St. Gallen Report 2013 is Leading Brands JLT. The latest version released by its developer is 1.00.
To install St. Gallen Report 2013 on your iOS device, just click the green Continue To App button above to start the installation process. The app is listed on our website since 2013-11-19 and was downloaded 1 times. We have already checked if the download link is safe, however for your own protection we recommend that you scan the downloaded app with your antivirus. Your antivirus may detect the St. Gallen Report 2013 as malware if the download link is broken.
How to install St. Gallen Report 2013 on your iOS device:
- Click on the Continue To App button on our website. This will redirect you to the App Store.
- Once the St. Gallen Report 2013 is shown in the iTunes listing of your iOS device, you can start its download and installation. Tap on the GET button to the right of the app to start downloading it.
- If you are not logged-in the iOS appstore app, you'll be prompted for your your Apple ID and/or password.
- After St. Gallen Report 2013 is downloaded, you'll see an INSTALL button to the right. Tap on it to start the actual installation of the iOS app.
- Once installation is finished you can tap on the OPEN button to start it. Its icon will also be added to your device home screen.
